JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
24h
Current
Min
14.6
Max
14.96
Recommendations | Buy |
---|---|
12 Months Forecast | +56.46% upside |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
19 gru 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 23 USD 56.46%
High 30 USD
Low 16 USD
Based on 3 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Buy
3 ratings
1
Buy
2
Hold
0
Sell
Based on 3 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$